Furthermore, patients with type 2 diabetes with end-stage renal disease have elevated fasting plasma levels of glucagon, increasing linearly from chronic kidney disease stages 1 to 5 (20). The gene discussed is GCG; the disease is type 2 diabetes mellitus.